Pharma Industry
Industry: Email Alert RSS FeedPharma Marketletter
View more issues:
Articles in April, 2003 issue of Pharma Marketletter
- Stock Commentary - Europe.
- Revenues up at Merck & Co on key drug sales, profits hit by increased spending.
- DTB finds no evidence of autism with MMR.
- US states "failing to monitor effects of Rx prior authorization under Medicaid".
- Israel's health reforms: a "basket" case, a road map and a heavyweight.
- Stock Commentary - Europe.
- Firms overcharged $6.1M for 11 drugs: HHS.
- US Court OKs Michigan preferred drug lists.
- Regeneron dives as statement on Phase III obesity trial alarms investors.
- Array BioPharma lowers forecasts.
- Tokyo pharma stocks - week to April 7.
- S-P, Novartis link up on asthma product.
- Biogen raises forecast, shares up on news.
- OSI Pharma shares gyrate as investors react to Tarceva update.
- Shock French move as Minister slashes reimbursement on 617 drugs.
- S African Rx price panel plan is extremist and against free trade, says NAPM.
- Cytos beats forecasts with 2002 results.
- Merck & Co's Emend cleared by FDA for nausea in cancer chemotherapy.
- UK NICE to view statins, antipsychotics, etc.
- ProEthic transdermal ketoprofen deal.
- Lilly "spying" prompts Hungarian price move.
- EU Parliament votes to support stem cell research ban.
- AstraZeneca rations drug supplies to Canadian pharmacies.
- UPDATE: Allos Therapeutics' brain cancer trial misses primary endpoint.
- Biogen's 1st-qtr profit down, underlying growth edges up on Avonex sales.
- Stock Commentary - Europe.
- Stock Commentary - Tokyo.
- Licensing still vital to SkyePharma in 2003.
- SangStat boosted by new data on inflammatory bowel disease treatment.
- War, terror and terrorism overshadow normally sanguine FDLI meeting.
- Stock Commentary - New York.
- Profits flat at Novartis despite sales growth.
- Novartis' Certican tops azathioprine.
- Takeda forecasts 315B yen profit in 2004.
- Stock Commentary - New York.
- California directs HMOs over switched drugs.
- Merck KGaA lifted by Erbitux trial review.
- ImClone to restate earnings for 2001/02.
- As FDA moves to efficient risk management, pharma "must make similar reforms".
- US HHS warns of FDA workload fears; should 10-month NDA goal be extended?
- Stock Commentary - Tokyo.
- Xenova: progress with therapeutic vaccines.
- Red tape delays AIDS grant to South Africa.
- Pfizer boosted by disposals in 1st-qtr, double-digit sales and EPS growth.
- Europe goes on-line for health info, but still prefers traditional sources.
- Stock Commentary - New York.
- Update - AstraZeneca 's Crestor: ACC studies.
- Cyprotex' losses soar after 1st trading period.
- Stock Commentary - Europe.
- Profits and sales up at J&J in first quarter on higher prescription turnover.
- XOMA and Genentech expand Raptiva collaboration.
- Evans aborts OGS bid, Celltech set to triumph.
- Antidepressant sales boost Forest in 4th qtr.
- Update: Regeneron dives on Phase III obesity trial.
- Threats to innovation could see drug R&D fall into a "death spiral," says Eli Lilly CEO.
- Genzyme fined L6.8M over market abuse regarding Cerezyme in the UK.
- Pharmacia gets US approval for acromegaly treatment Somavert.
- China tightens controls on drugs and biologicals, approves food/drug admin.
- Forest's memantine Ph III Alzheimer's trial.
- The future of orphan drugs: FDLI meeting.
- GSK faces challenging times, says Wood Mackenzie.
- Allos Therapeutics' brain cancer trial misses primary endpoint.
- Chugai chief reviews pipeline, business prospects post Roche alliance.
- Underlying growth beats forecasts at Lilly.
- AstraZeneca says Lipitor users benefit from switch to Crestor.
- US Congress urged over web pharmacy.
- Fujisawa adopts fresh management strategy.
- Schwarz lifts forecasts on strong generic sales.
- China pharma ind to become competitive.
- Gedeon Richter sees product mix improve in 2002.
- Amgen outperforms in 1st qtr, raises forecast.
- Exanta study tops expectations.
- Roche CEO reiterates 2003 forecasts.
- State of play in human embryonic stem cell research: Euro Commission report.
- McClellan says FDA will encourage generics but slams makers over approval delays.
- Stock Commentary - Tokyo.
- Evans aborts OGS bid, Celltech set to triumph.
- Pfizer deal finally cleared by FTC and trading to commence; Hassan's future?
- Renagel sales boost Genzyme in 1st-qtr.
- Losses up at TKT but Replagal sales recover.
Brought to you by CBS MoneyWatch.com
- Best- and Worst-Paid College Degrees
- 6 Things You Should Never Do on Twitter or Facebook
- How Much Sleep Do You Really Need?
- 6 Big Myths about Gas Mileage
- 5 Rules for Immediate Annuities
- Death in the Family: 12 Things to Do Now
- Dumbest Things You Do With Your Money
- 6 Online Networking Mistakes to Avoid
- 401(k) Mistakes to Avoid
- 5 Economic Scenarios to Keep You Up at Night
- The Real ‘Best Places to Retire’
- Best Credit Cards for You
- 12 Tough Questions to Ask Your Parents
- The Real ‘Best Colleges’
- Home Buyer Tax Credit: How to Cash In
- Why You Shouldn't Bash Cash
- 8 Phony 'Bargains' and Better Alternatives
- Danger: 3 Debit Card Scams to Avoid
- 6 Myths About Gas Mileage
- 29 Fees We Hate Most
- Quick and Easy Ways to Boost Returns
- Best Stocks to Buy Now
- Lower Your Taxes: 10 Moves to Make Now
- New Jobs: 8 Lessons from Real-Life Career Switchers
- The New Job Market: Who Wins and Who Loses?
- Health Care Reform's Public Option: Everything You Need to Know
- Volunteer Work When Unemployed: Should You Work for Free?
- Whose Recovery Is This?
- Long-Term-Care Insurance: 4 Biggest Risks to Avoid
Most Recent Health Articles
Most Recent Health Publications
Most Popular Health Articles
- Make running easier: with this unique 'pose running' technique, you'll learn to actually enjoy your fat-burning sessions
- 50 home remedies that work: these safe, fast, and effective fixes will relieve what ails you - Cover Story
- Detox in 7 days: a detoux diet can help you shed up to 10 pounds and leave you feeling terrific. Our weeklong plan shows you how to lose the weight and keep it off - Cover story
- Treat sinusitis naturally: breath easy and relieve sinus pressure with these remedies - Quick Fixes and Long-Term Solutions
- All about nightshades: explore the hidden hazards of your favorite food with macrobiotic nutritionist Lino Stanchich



